idea
brain
intim
relat
complaint
unrefresh
sleep
musculoskelet
pain
fatigu
suffer
novel
notion
origin
found
remot
past
millennia
origin
signific
immers
religi
belief
evil
thought
sin
human
behavior
special
opportun
redempt
ritual
perform
healer
sacrific
prayer
consequ
medic
attempt
evad
understand
even
day
rheumatologist
often
ask
assess
manag
afflict
patient
say
relev
focu
interest
peopl
discern
object
evid
arthrit
immunolog
diseas
patholog
even
though
patient
search
understand
help
afflict
suffer
may
face
reject
physician
exploit
remedi
improv
sleep
cure
bodili
complaint
matter
despair
hopeless
clearli
simpli
describ
ecclesiast
day
work
grief
pain
even
night
mind
rest
meaningless
despit
ecclesiast
pessimist
perspect
troubl
mankind
chapter
focus
effort
bring
scientif
understand
physiolog
brain
allow
us
better
understand
origin
manag
widespread
pain
suffer
disabl
peopl
acquir
varieti
diagnost
label
variou
medic
disciplin
though
mere
diagnosi
provid
understand
treatment
turn
last
centuri
peopl
given
label
fibros
english
neurologist
william
gower
believ
basi
patient
pain
limb
back
result
inflamm
fibrou
tissu
systemat
studi
infecti
diseas
patholog
could
verifi
term
becam
wastebasket
diagnosi
use
rheumatologist
differenti
patient
similar
symptom
object
evid
diseas
patholog
medic
specialist
afflict
peopl
would
visit
appli
explan
relat
specialti
focu
interest
see
tabl
list
healthcar
specialist
provid
area
interest
diagnost
label
provid
patient
medic
field
becom
complic
symptom
found
patient
known
diseas
even
though
diseas
success
treat
wellestablish
diseasemodifi
substanc
may
remain
chronic
ill
unrefresh
sleep
widespread
pain
tender
chronic
fatigu
psycholog
distress
featur
often
occur
patient
system
lupu
erythematosi
rheumatoid
arthriti
without
object
evid
arthrit
neuroendocrin
immunolog
diseas
patholog
commun
rheumatologist
abandon
term
illunderstood
fibros
adopt
nowpopular
descript
diagnosi
fibromyalgia
fm
fibromyalgia
syndrom
fm
formal
criteria
diagnosi
approv
american
colleg
rheumatolog
permit
epidemiolog
studi
determin
preval
syndrom
subsequ
approxim
us
popul
women
men
found
affect
diffus
musculoskelet
pain
debilit
fatigu
five
european
countri
franc
germani
itali
portug
spain
affect
popul
women
men
make
rheumat
disord
second
common
rheumat
ailment
osteoarthr
time
infecti
diseas
expert
note
pain
fatigu
symptom
prevail
long
acut
infecti
diseas
past
various
diagnos
patient
postinfecti
postvir
syndrom
myalgic
encephalomyel
epstein
viru
syndrom
sporad
cluster
mysteri
ailment
appear
diagnost
label
attribut
geograph
locat
eg
lo
angel
counti
hospit
diseas
also
known
time
atyp
poliomyel
akureyri
diseas
also
call
iceland
diseas
london
royal
free
hospit
diseas
subsequ
thought
form
mass
hysteria
absenc
verifi
evid
specif
infecti
agent
inflammatori
diseas
patholog
prove
perplex
infecti
diseas
specialist
lack
object
evid
specif
viru
specif
infecti
diseas
led
committe
advisori
expert
us
centr
diseas
control
formal
criteria
current
diagnosi
chronic
fatigu
syndrom
cf
came
exist
vagu
descript
label
emerg
much
chagrin
affect
american
patient
advoc
special
recognit
govern
health
agenc
prefer
term
chronic
immun
defici
syndrom
uk
label
chronic
infecti
neuromyasthenia
enceph
prefer
often
overlap
among
variabl
clinic
criteria
adopt
committe
variou
medic
disciplin
author
refer
patient
come
umbrella
cluster
overlap
ailment
see
tabl
overrid
common
featur
absenc
known
clinic
featur
diseas
sign
abnorm
radiolog
hematolog
histolog
chemic
metabol
immunolog
test
nevertheless
hunt
viral
etiolog
persist
current
report
scienc
preval
retroviru
xenotrop
murin
leukemia
virusrel
viru
xmrv
find
patient
cf
two
year
sever
scientif
report
failur
replic
initi
find
led
formal
retract
journal
novemb
viral
etiolog
howev
remain
relev
select
popul
postfebril
persist
chronic
fatigu
diffus
myalgia
exampl
follow
outbreak
toronto
sever
acut
respiratori
syndrom
sar
surviv
residu
respiratori
diseas
year
later
persist
diffus
myalgia
disabl
fatigu
weak
unrefresh
sleep
anomal
increas
sleep
eeg
alpha
eeg
sleep
cyclic
altern
pattern
cap
nonrem
sleep
possibl
sar
coronaviru
known
enter
brain
acut
phase
may
continu
advers
influenc
sleep
wake
brain
associ
physic
behavior
symptom
absenc
medic
diseas
peopl
illunderstood
poor
sleep
qualiti
chronic
pain
fatigu
tend
cast
dark
chasm
vagu
psychiatr
label
psychiatr
diagnost
label
chang
cours
five
revis
american
psychiatr
associ
apa
diagnost
statist
manual
mental
disord
dsm
rang
neurasthenia
hyster
convers
disord
somatoform
pain
disord
somat
disord
feckless
diagnosi
somat
symptom
disord
chain
psychiatr
label
repres
histori
collect
transient
agreement
gener
us
psychiatr
committe
appli
form
presum
scientif
explan
bodili
complaint
sick
satisfactori
medic
psycholog
explan
earlier
psychiatr
diagnos
abandon
favor
empir
presum
less
controversi
descript
label
seen
tabl
diagnost
label
adopt
variou
group
health
specialist
afflict
similar
scientif
explanatori
dilemma
prescientif
evolut
knowledg
peopl
ailment
given
variou
religi
spiritu
explan
remedi
stem
particular
prayer
ritual
andor
special
natur
remedi
nonwestern
societi
system
belief
respect
special
name
remedi
method
deem
featur
culturebound
syndrom
exampl
hwabyung
korean
folk
ill
character
insomnia
pain
fatigu
weak
gastrointestin
symptom
emot
distress
chines
patient
sleep
difficulti
headach
variou
pain
fatigu
sexual
dysfunct
term
shenj
shuairuo
societi
belief
affect
peopl
vital
essenc
lost
life
threaten
indian
societi
term
dhat
hindu
similar
belief
danger
self
loss
essenti
sexual
fluid
latinamerican
societi
frighten
emot
distress
peopl
similar
sleep
somat
symptom
consid
afflict
susto
soul
loss
even
western
societi
clear
medic
understand
caus
treatment
illdefin
symptom
culturebound
belief
system
method
treat
ill
continu
prevail
societi
henc
larg
industri
purveyor
herbal
substanc
acupunctur
moxibust
procedur
useless
remedi
variou
vitamin
miner
lack
faith
medic
explan
hope
nontradit
method
would
remedi
mysteri
rheumat
symptom
rather
focus
tradit
rheumat
interest
joint
connect
tissu
muscl
current
interest
shift
central
nervou
system
sourc
hypersensit
applic
pressur
variou
predesign
region
bodi
pain
behavior
readili
observ
rheumatologist
examin
patient
musculoskelet
system
base
upon
experiment
evid
moldofski
propos
hypothesi
sleepingwak
brain
integr
somat
behavior
symptom
illunderstood
pain
fatigu
distress
often
disabl
chronic
ill
hypothesi
give
rise
follow
question
brain
connect
poorli
understood
somat
behavior
symptom
understand
disturb
sleepingwak
brain
favor
influenc
manag
suffer
patient
chapter
review
advanc
scientif
understand
brain
intim
connect
widespread
musculoskelet
pain
fatigu
psycholog
distress
symptom
previous
presum
unexplain
medic
ill
led
current
advanc
manag
pioneer
work
moldofski
colleagu
yield
two
critic
import
find
regard
relationship
sleep
widespread
musculoskelet
pain
fatigu
rheumatolog
patient
without
known
medic
diseas
eeg
sleep
disturb
fm
patient
report
persist
poor
sleep
qualiti
impair
qualiti
life
experiment
sleep
disturb
healthi
individu
induc
fmlike
musculoskelet
pain
tender
manifest
disturb
sleep
typic
compris
experi
light
unrefresh
sleep
nocturn
restless
frequent
awaken
time
sleeprel
loud
snore
breath
problem
period
involuntari
leg
movement
typic
variat
diurnal
pattern
symptom
upon
awaken
poor
qualiti
sleep
patient
usual
experi
gener
muscular
stiff
diffus
pain
profound
fatigu
unchang
even
increas
compar
previou
even
report
improv
symptom
improv
energi
late
morn
midafternoon
thereaft
downhil
cours
symptom
day
progress
narrow
period
improv
disabl
patient
rare
occas
might
achiev
rest
night
sleep
improv
symptom
follow
day
inde
unrefresh
nonrestor
sleep
close
correl
widespread
pain
tender
point
fm
psycholog
distress
fm
subject
light
unrefresh
sleep
diurnal
impair
speed
perform
complex
cognit
task
accompani
sleepi
fatigu
neg
mood
psycholog
impair
could
account
function
disabl
encount
work
environ
social
behavior
may
associ
predisposit
emot
hypersensit
result
distrust
insecur
attach
person
shown
associ
alphaeeg
anomali
sleep
disabl
behavior
symptom
commonli
associ
disturb
physiolog
sleep
fm
symptom
link
subject
poor
sleep
qualiti
object
psg
measur
continu
consider
interest
determin
pathophysiolog
ill
earli
aspect
anomal
chang
eeg
sleep
physiolog
identifi
fm
patient
consid
consist
subject
poor
qualiti
sleep
nocturn
polysomnographi
psg
show
promin
eeg
alpha
frequenc
hz
rhythm
central
eeg
region
stage
slowwav
sleep
sw
nrem
sleep
see
fig
less
frequent
patient
sever
diminish
absent
delta
sw
hauri
hawkin
notic
alpha
eeg
anomali
coincid
delta
frequenc
hz
slow
wave
sw
coin
term
sleep
describ
small
group
depress
psychiatr
patient
poorli
understood
ill
complain
chronic
somat
malais
fatigu
subsequ
moldofski
colleagu
report
anomali
patient
socal
fibros
later
consid
rheumatologist
wastebasket
diagnosi
lack
replic
evid
presum
inflamm
fibrou
tissu
subsequ
symptom
relabel
fm
fm
anomal
alpha
eeg
sleep
seen
predominantli
brain
area
contrast
alpha
eeg
frequenc
occur
quiet
wake
local
occipit
region
subsequ
report
anomal
increas
alpha
eeg
activ
nrem
sleep
report
fm
patient
patient
fm
howev
heterogen
respect
exhibit
alpha
anomali
alpha
activ
nrem
sleep
specif
fm
sinc
occur
patient
pain
rheumat
diseas
moreov
describ
occur
patient
primari
insomnia
eeg
alphalik
rhythm
associ
mentat
alpha
occur
nrem
sleep
may
repres
vigil
arous
state
interfer
bodili
restor
function
abnorm
eeg
sleep
featur
may
account
common
aspect
impair
sleep
qualiti
symptom
light
sleep
sleep
mentat
extern
environment
awar
intern
selfawar
subject
discomfort
sens
vigil
shown
associ
underli
faulti
person
characterist
peopl
promin
alpha
eeg
sleep
anomali
physic
ill
stem
faulti
interact
pattern
childhood
person
develop
formal
person
test
peopl
alpha
eeg
sleep
anomali
fm
show
pattern
overal
distrust
insecur
interperson
relationship
consequ
pervas
sens
insecur
distrust
ingrain
person
thought
make
difficult
accept
medic
therapeut
effort
result
perpetu
chronic
physic
ill
behavior
second
physiolog
compon
impair
sleep
qualiti
thought
specif
eeg
pattern
contribut
unstabl
nonrestor
sleep
major
diagnost
featur
fm
cf
object
physiolog
featur
sleep
eeg
sleep
compris
high
frequenc
cap
cap
phenomenon
occur
variabl
throughout
nrem
sleep
character
frequenc
approxim
cycl
per
second
see
fig
specif
type
cap
report
reflect
measur
rel
sleep
patient
fm
cf
unstabl
nonrestor
sleep
commonli
report
increas
cap
activ
sleep
eeg
domin
rhythm
cap
signific
ancillari
increas
autonom
peripher
emg
activ
seen
cap
increas
cap
associ
sleep
stabil
commonli
found
young
asymptomat
healthi
peopl
subgroup
cap
cap
physiolog
evid
progress
increas
sleep
instabl
high
amount
cap
correl
sever
pain
measur
number
tender
point
fm
eeg
cap
especi
cap
associ
patholog
sleep
character
physiolog
evid
motor
autonom
nervou
system
abnorm
eg
period
limb
movement
plm
sleep
apnea
disord
clinic
signific
period
psg
sleep
disord
found
larg
sampl
us
patient
fm
multicent
psg
studi
fm
patient
femal
mean
bodi
mass
index
fm
year
approxim
moder
sever
respiratori
index
plm
disord
sedentari
behavior
result
weight
gain
obes
may
promot
sleep
apnea
disord
coincid
cap
eeg
unstabl
nonrestor
sleep
anoth
featur
sleep
eeg
disturb
report
fm
decreas
stage
eeg
sleep
spindl
presenc
eeg
sleep
spindl
characterist
stage
nrem
sleep
hypothes
physiolog
featur
sleep
stabil
hypothesi
support
shorter
durat
stage
sleep
period
normal
domin
cap
addit
increas
frequenc
eeg
sleep
stage
shift
increas
sleep
awaken
decreas
sleep
effici
ratio
time
asleeptim
bed
moreov
reduct
sw
fm
patient
one
studi
show
decreas
sw
correl
highphas
eeg
alpha
rhythm
find
reduc
sw
fm
patient
also
coincid
nocturn
neuroendocrin
abnorm
increas
nocturn
cortisol
level
decreas
releas
growth
hormon
gh
quantit
studi
suggest
durat
sw
serv
regul
homeostasi
correl
amount
prior
wake
sw
increas
follow
extend
wake
decreas
nocturn
sleep
follow
daytim
nap
contain
sw
decreas
amount
sw
fm
might
indic
impair
sw
homeostat
drive
sleep
abnorm
fm
patient
consist
report
studi
exampl
fm
patient
report
significantli
differ
control
respect
alpha
sleep
eeg
activ
durat
sw
unclear
whether
discrep
result
heterogen
sleep
patholog
fm
patient
technic
consider
differ
score
sleep
eeg
alpha
anomali
nighttonight
variabl
mani
sleep
measur
includ
sw
among
patient
fm
poor
sleep
qualiti
shown
key
viciou
cycl
feel
unrefresh
sleep
morn
achingstiff
fatigu
dyscognit
sever
prospect
clinic
studi
report
correl
poor
sleep
qualiti
fm
symptom
statist
path
analysi
larg
popul
fm
patient
found
night
increas
sleep
disturb
correl
increas
pain
predict
poorer
physic
function
subsequ
greater
depress
anoth
studi
poor
sleep
qualiti
mediat
impact
increas
pain
upon
fatigu
studi
extend
previou
find
night
poor
sleep
follow
day
increas
pain
moreov
account
effect
posit
neg
event
pain
daili
mood
rate
sleep
durat
qualiti
prospect
relat
affect
fatigu
inadequ
sleep
cumul
effect
neg
affect
prevent
mood
recoveri
day
high
number
neg
event
describ
moldofski
colleagu
first
attribut
function
disturb
brain
etiolog
core
promot
fm
symptom
public
show
interrupt
sw
auditori
stimuli
fmlike
state
includ
variabl
ach
fatigu
increas
sensit
pain
pressur
could
induc
healthi
normal
nonathlet
subject
also
show
small
pilot
studi
similar
experiment
prospect
sleep
symptom
test
circumst
sever
member
univers
toronto
track
team
experi
pain
fatigu
symptom
preliminari
find
suggest
aerob
physic
fit
involv
prevent
reduc
emerg
symptom
sinc
research
confirm
select
depriv
disrupt
sleep
induc
increas
bodili
sensit
decreas
pain
threshold
report
nonrestor
sleep
one
studi
involv
presum
fit
us
militari
men
found
reduct
pain
threshold
albeit
significantli
differ
control
anoth
experiment
clinic
studi
sleep
depriv
alter
somatosensori
nonnocicept
function
furthermor
effect
interrupt
sw
increas
sensit
pain
nonpain
stimuli
bright
light
loud
sound
strong
odor
studi
select
sleep
depriv
middleag
sedentari
women
similar
major
demograph
popul
fm
patient
also
produc
impair
diffus
noxiou
inhibitori
control
dnic
similar
observ
fm
patient
recoveri
sleep
depriv
result
increas
amount
sw
normal
pain
threshold
import
sw
maintain
homeostat
properti
cn
purport
involv
downregul
synaps
synapt
upregul
featur
state
central
sensit
pain
augment
may
caus
disturb
physiolog
sleep
lead
impair
sleep
qualiti
nonrestor
sleep
symptom
consequ
total
sleep
depriv
rem
sleep
depriv
advers
affect
pain
threshold
pain
behavior
also
occur
result
experiment
induc
loss
termin
four
hour
sleep
rem
nonrem
sleep
despit
absenc
specif
structur
patholog
evid
disord
metabol
function
involv
sleepingwak
brain
includ
decreas
sleeprel
prolactin
decreas
gh
metabolit
disturb
hypothalamiccort
adren
axi
elev
cerebr
spinal
fluid
substanc
p
sp
furthermor
specif
dysfunct
neurotransmitt
function
shown
contribut
bodili
sensit
disord
sleep
exampl
inhibit
serotonin
synthesi
pchlorophenylalanin
induc
insomnia
hyperalges
state
anim
human
increas
level
sp
found
csf
fm
patient
led
experiment
studi
demonstr
sp
oper
neurokinin
nk
pathway
influenc
nocicept
sleep
intracerebr
ventricular
administr
sp
suffici
quantiti
induc
nocicept
respons
mice
delay
onset
sleep
provok
awaken
sleep
receptor
antagonist
revers
interf
effect
upon
sleep
sp
research
demonstr
block
spinduc
insomnia
prior
treatment
mice
receptor
antagonist
provid
support
notion
arous
effect
increas
sp
sleepingwak
brain
moreov
research
provid
experiment
anim
model
studi
sleep
disturb
musculoskelet
pain
function
neuroimag
fm
patient
support
hypothesi
deficit
cn
inhibit
central
pain
augment
fm
patient
report
prematur
decreas
gray
matter
volum
cingul
insular
medial
frontal
cortic
parahippocamp
gyri
may
associ
affect
disturb
chronic
widespread
pain
wherea
durat
pain
function
pain
disabl
relat
gray
matter
volum
suggest
trend
reduct
anterior
cingul
cortex
acc
gray
matter
volum
anoth
brain
imag
studi
fm
patient
show
lower
acc
connect
bilater
hippocampi
amygdala
brainstem
rostral
ventromedi
medulla
brain
area
involv
descend
inhibitori
modul
pain
increas
central
nervou
system
sensit
furthermor
sleep
depriv
advers
effect
pain
percept
cognit
function
alter
dopamin
metabol
receptor
striatum
merit
studi
neurotransmitt
involv
sleepwak
mechan
increas
overnight
sympathet
activ
use
electrocardiograph
methodolog
consist
notion
circadian
autonom
metabol
dysfunct
associ
arous
disturb
sleep
patient
fm
conclus
continu
search
biolog
behavior
etiolog
factor
result
absenc
specif
trigger
event
onset
symptom
absenc
medic
explanatori
specif
trigger
etiolog
agent
led
belief
combin
genet
environment
predisposit
pain
fatigu
syndrom
accordingli
pattern
specif
gene
may
becom
activ
varieti
noxiou
trigger
influenc
exampl
includ
industri
motor
vehicl
accid
psycholog
traumat
event
eg
posttraumat
stress
injuri
viral
infect
consequ
chronic
post
viral
cf
eg
postvir
sar
potenti
trigger
event
may
advers
affect
oper
sleepingwak
brain
associ
abnorm
metabol
neurophysiolog
function
result
neurophysiolog
dysfunct
affect
inhibitori
reciproc
excit
sensori
oper
clinic
manifest
hypersensit
variou
extern
noxiou
stimuli
eg
applic
pressur
loud
nois
bright
light
unpleas
odor
organ
sensori
dysfunct
may
affect
reactiv
hypermotil
eg
irrit
bowel
bladder
syndrom
clinic
experi
may
evolv
psycholog
distress
pattern
selfperpetu
chronic
unrefresh
sleep
widespread
pain
fatigu
psychosoci
behavior
problem
search
help
affect
often
femal
label
diagnos
reflect
educ
special
focu
interest
belief
system
particular
method
treatment
employ
health
profession
practic
see
tabl
past
sever
year
three
cn
drug
pregabalin
drug
anticonvuls
properti
duloxetin
milnacipran
drug
initi
market
antidepress
approv
treatment
fm
us
food
drug
administr
fda
pregabalin
duloxetin
approv
health
canada
none
drug
approv
european
medicin
agenc
neurotransmitt
modulatori
agent
pregabalin
ligand
caus
increas
cellular
express
calcium
channel
reduc
express
sp
noradrenalin
studi
show
drug
improv
pain
qualiti
sleep
fatigu
fm
duloxetin
milnacipran
reuptak
inhibitor
known
help
improv
mood
also
benefit
pain
sleep
anim
studi
neuropath
pain
human
us
multicent
random
placebocontrol
trial
rct
sodium
oxyb
given
qh
dose
improv
sleep
physiolog
reduc
percent
cap
rate
increas
sw
addit
improv
self
rate
qualiti
sleep
reduct
pain
fatigu
fm
patient
metaanalysi
five
rct
trial
mg
cyclobenzaprin
given
variabl
time
day
show
overal
global
improv
fm
shortterm
modest
improv
pain
moder
improv
sleep
improv
fatigu
tender
point
howev
patient
experienc
untoward
effect
commonli
drowsi
dizzi
dri
mouth
recent
twosit
rct
mg
cyclobenzaprin
bedtim
mean
dose
mg
show
improv
pain
tender
depress
sleep
qualiti
sleep
stabil
measur
sleep
eeg
cap
subject
take
low
dose
cyclobenzaprin
versu
placebo
group
night
restor
sleep
accompani
improv
fatigu
depress
drug
fda
develop
effort
direct
remedi
aspect
abnorm
neuroendocrin
function
eg
one
third
patient
low
level
insulinlik
growth
factor
surrog
marker
low
gh
secret
treat
daili
inject
gh
random
placebocontrol
doubleblind
studi
increas
reduct
pain
tender
hand
gh
reduc
patient
fm
improv
symptom
high
cost
need
daili
inject
make
use
impract
singl
nonrct
pramipexol
dopamin
agonist
report
help
pain
fatigu
overal
function
subset
fm
patient
half
also
take
narcot
consist
abnorm
report
secret
melatonin
patient
either
cf
fm
administr
found
use
control
studi
furthermor
use
morn
bright
light
treatment
tend
modifi
time
nocturn
secret
melatonin
help
season
affect
disord
benefit
sleep
pain
mood
symptom
patient
fm
final
patient
primari
sleep
disord
restless
legsplm
disord
sleep
apnea
yet
subject
rct
pain
fatigu
wellestablish
remedi
condit
particular
studi
pramipexol
similar
dopamin
agonist
requir
determin
whether
improv
note
patient
may
relat
reduct
restless
legsplm
sleep
disord
occur
patient
conclus
advanc
scientif
understand
brain
intim
connect
widespread
musculoskelet
pain
fatigu
psycholog
distress
symptom
previous
presum
unexplain
medic
ill
current
advanc
medic
knowledg
lead
improv
manag
fm
similar
pervas
syndrom
chronic
unrefresh
sleep
diffus
myalgia
fatigu
psycholog
distress
